Latest Information Update: 12 Nov 2002
At a glance
- Originator Nonindustrial source
- Mechanism of Action Cannabinoid receptor antagonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- No development reported Anorexia nervosa
Most Recent Events
- 04 Dec 2000 Preclinical development for Anorexia nervosa in USA (Unknown route)